product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
DNA-PK (3H6) Mouse mAb
catalog :
12311
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
3H6
reactivity :
human
application :
western blot, immunocytochemistry
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; fig 4
Young L, Marzio A, Pérez Durán P, Reid D, Meredith D, Roberti D, et al. TIMELESS Forms a Complex with PARP1 Distinct from Its Complex with TIPIN and Plays a Role in the DNA Damage Response. Cell Rep. 2015;13:451-459 pubmed publisher
  • western blot; human; fig 5
Nakajima N, Hagiwara Y, Oike T, Okayasu R, Murakami T, Nakano T, et al. Pre-exposure to ionizing radiation stimulates DNA double strand break end resection, promoting the use of homologous recombination repair. PLoS ONE. 2015;10:e0122582 pubmed publisher
Wang Y, Hariharan A, Bastianello G, Toyama Y, Shivashankar G, Foiani M, et al. DNA damage causes rapid accumulation of phosphoinositides for ATR signaling. Nat Commun. 2017;8:2118 pubmed publisher
product information
SKU :
12311S
Product-Name :
DNA-PK (3H6) Mouse mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, Mk
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
450
Host :
Mouse
Target :
DNA-PK
Primary-Protein :
DNA-PK
Alt-Names :
DNA-PK catalytic subunit,DNA-PKcs,DNA-dependent protein kinase catalytic subunit,DNAPK,DNPK1,HYRC,HYRC1,PRKDC,XRCC7,hyper-radiosensitivity of murine scid mutation, complementing 1,p350,p460,protein kinase, DNA-activated, catalytic polypeptide
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.